Voyager Therapeutics announced the appointment of Grace Colon, Ph.D., to its Board of Directors. Dr. Colon has more than 25 years of experience as a healthcare leader, investor and entrepreneur; she most recently served as President, CEO and Director of clinical-stage biotechnology company InCarda Therapeutics.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VYGR:
- Voyager Therapeutics Appoints Grace E. Colón, Ph.D., to its Board of Directors
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Voyager Therapeutics Reports Third Quarter 2022 Financial and Operating Results
- Voyager Therapeutics Announces Third Quarter 2022 Conference Call and Webcast